Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
With
Elan Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients at least 18 years of age with at least a six-month history of Crohn's disease and who are currently receiving Remicade and are not in remission (CDAI greater than/equal to 150)
Women must not be breastfeeding or pregnant, and must not become pregnant during the study.
Clareo Health | Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
